Search Results | Diabetes | American Diabetes Association

1-14 of 14

Sort by

Sort Order Select

Meeting Abstracts

959-P: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

PHILIP HOME, VANITA R. ARODA, MIR SOHAIL FAZELI, CRAIG WHITTINGTON, HARDIK GOSWAMI, ALKA SHAUNIK, MIR-MASOUD POURRAHMAT, LAWRENCE BLONDE, SANJAY KALRA

Diabetes 2020;69(Supplement_1):959-P

DOI: https://doi.org/10.2337/db20-959-P

Published: 01 June 2020

View article

Meeting Abstracts

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

JULIO ROSENSTOCK, AMAR ALI, JURIS J. MEIER, FRANCESCO GIORGINO, CRISTIAN GUJA, MARTIN PRAZNY, ROBERT LUBWAMA, ELISABETH SOUHAMI, LAWRENCE BLONDE

Diabetes 2020;69(Supplement_1):88-LB

DOI: https://doi.org/10.2337/db20-88-LB

Published: 01 June 2020

View article

Meeting Abstracts

1517-P: Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)

LAWRENCE BLONDE, ALAN WILK, ALINA BOGDANOV, JOE VASEY, LEE KALLENBACH, MICHAEL DURKIN

Diabetes 2020;69(Supplement_1):1517-P

DOI: https://doi.org/10.2337/db20-1517-P

Published: 01 June 2020

View article

Meeting Abstracts

345-OR: A Retrospective U.S. Real-World Evidence Study on Glycemic Goal Achievement within 2 Years Post-Basal Insulin Initiation

XUEJUN V. PENG, PHILLIP R. HUNT, TERRY A. DEX, ROBERT LUBWAMA, NEIL SKOLNIK, LAWRENCE BLONDE

Diabetes 2019;68(Supplement_1):345-OR

DOI: https://doi.org/10.2337/db19-345-OR

Published: 01 June 2019

View article

Meeting Abstracts

1106-P: Predictive Modeling Suggests Subgroup Effects for Severe Hypoglycemia in T2DM Patients Treated with Gla-300 vs. IDeg: The LIGHTNING Study

IRENE HRAMIAK, MARTIN HALUZIK, JUKKA WESTERBACKA, ZSOLT BOSNYAK, BJORN ELIASSON, LAWRENCE BLONDE, TIMOTHY S. BAILEY

Diabetes 2019;68(Supplement_1):1106-P

DOI: https://doi.org/10.2337/db19-1106-P

Published: 01 June 2019

View article

Meeting Abstracts

1143-P: Secondary Metformin Monotherapy Failure in Type 2 Diabetes Mellitus Patients

TRACEY WEISS, KRISTY IGLAY, PRIYA VERMA, SWAPNIL RAJPATHAK, LINGFENG YANG, LAWRENCE BLONDE

Diabetes 2019;68(Supplement_1):1143-P

DOI: https://doi.org/10.2337/db19-1143-P

Published: 01 June 2019

View article

Meeting Abstracts

1139-P: Influence of Screening HbA_1c Levels on Glucose Control Achieved when Switching to iGlarLixi in T2D Inadequately Controlled on GLP-1RA and OAD(s)

STEFANO DEL PRATO, LAWRENCE BLONDE, ROBERT R. HENRY, VANITA R. ARODA, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, JULIO ROSENSTOCK

Diabetes 2019;68(Supplement_1):1139-P

DOI: https://doi.org/10.2337/db19-1139-P

Published: 01 June 2019

View article

Meeting Abstracts

1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

JULIO ROSENSTOCK, LAWRENCE BLONDE, STEFANO DEL PRATO, ROBERT R. HENRY, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, VANITA R. ARODA

Diabetes 2019;68(Supplement_1):1146-P

DOI: https://doi.org/10.2337/db19-1146-P

Published: 01 June 2019

View article

Meeting Abstracts

14-OR: The Cost of Chronic Kidney Disease Progression in Type 2 Diabetes Patients

LAWRENCE BLONDE, JOSEPH A. VASSALOTTI, DOMINIC PILON, WILLY WYNANT, MARYIA ZHDANAVA, PATRICK LEFEBVRE, JENNIFER VOELKER, ROBERT BAILEY, MICHAEL DURKIN

Diabetes 2019;68(Supplement_1):14-OR

DOI: https://doi.org/10.2337/db19-14-OR

Published: 01 June 2019

View article

Meeting Abstracts

149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s)

LAWRENCE BLONDE, JULIO ROSENSTOCK, STEFANO DEL PRATO, ROBERT R. HENRY, NAIM SHEHADEH, ELISABETH NIEMOELLER, ELISABETH SOUHAMI, JUNLONG WU, XIANGLING WANG, CHEN JI, VANITA R. ARODA

Diabetes 2019;68(Supplement_1):149-OR

DOI: https://doi.org/10.2337/db19-149-OR

Published: 01 June 2019

View article

Meeting Abstracts

Impact of Type 2 Diabetes (T2D) Duration on Response to iGlarLixi vs. IGlar—A Subanalysis of LixiLan-L

LAWRENCE BLONDE, LORI BERARD, ARAMESH SAREMI, YAO HUANG, VANITA ARODA, DENIS RACCAH

Diabetes 2018;67(Supplement_1):1094-P

DOI: https://doi.org/10.2337/db18-1094-P

Published: 01 July 2018

View article

Meeting Abstracts

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

SEAN D. SULLIVAN, TIMOTHY S. BAILEY, RONAN ROUSSEL, FANG L. ZHOU, ZSOLT BOSNYAK, RON PREBLICK, JUKKA WESTERBACKA, RISHAB GUPTA, LAWRENCE BLONDE

Diabetes 2018;67(Supplement_1):1056-P

DOI: https://doi.org/10.2337/db18-1056-P

Published: 01 July 2018

View article

Meeting Abstracts

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

SEAN D. SULLIVAN, TIMOTHY S. BAILEY, RONAN ROUSSEL, FANG L. ZHOU, ZSOLT BOSNYAK, RON PREBLICK, JUKKA WESTERBACKA, RISHAB GUPTA, LAWRENCE BLONDE

Diabetes 2018;67(Supplement_1):1057-P

DOI: https://doi.org/10.2337/db18-1057-P

Published: 01 July 2018

View article

Meeting Abstracts

Total and Severe Hypoglycemia Is Reduced with Use of Inhaled Technosphere Insulin (TI, Afrezza^®) Relative to Insulin Aspart in Type 1 Diabetes

LAWRENCE BLONDE, FRANK POMPILIO, SIMON R. BRUCE, MARSHALL L. GRANT, DAVID M. KENDALL

Diabetes 2018;67(Supplement_1):102-LB

DOI: https://doi.org/10.2337/db18-102-LB

Published: 01 July 2018

View article

NARROW

959-P: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

1517-P: Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)

345-OR: A Retrospective U.S. Real-World Evidence Study on Glycemic Goal Achievement within 2 Years Post-Basal Insulin Initiation

1106-P: Predictive Modeling Suggests Subgroup Effects for Severe Hypoglycemia in T2DM Patients Treated with Gla-300 vs. IDeg: The LIGHTNING Study

1143-P: Secondary Metformin Monotherapy Failure in Type 2 Diabetes Mellitus Patients

1139-P: Influence of Screening HbA_1c Levels on Glucose Control Achieved when Switching to iGlarLixi in T2D Inadequately Controlled on GLP-1RA and OAD(s)

1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

14-OR: The Cost of Chronic Kidney Disease Progression in Type 2 Diabetes Patients

149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s)

Impact of Type 2 Diabetes (T2D) Duration on Response to iGlarLixi vs. IGlar—A Subanalysis of LixiLan-L

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Total and Severe Hypoglycemia Is Reduced with Use of Inhaled Technosphere Insulin (TI, Afrezza^®) Relative to Insulin Aspart in Type 1 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only